CEFTAZIDIME (CEFTAZIDIME) — FDA Approval ANDA065482 (AUROBINDO PHARMA LTD)
CEFTAZIDIME (CEFTAZIDIME) — FDA Approval ANDA065482 (AUROBINDO PHARMA LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CEFTAZIDIME; Active ingredients: CEFTAZIDIME; Application number: ANDA065482.
| Brand name | CEFTAZIDIME |
|---|---|
| Active ingredients | CEFTAZIDIME |
| Application number | ANDA065482 |
| Sponsor | AUROBINDO PHARMA LTD |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20100528 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →